000 01505 a2200421 4500
005 20250517022132.0
264 0 _c20150921
008 201509s 0 0 eng d
022 _a1873-2623
024 7 _a10.1016/j.transproceed.2015.01.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVu, D
245 0 0 _aEfficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
_h[electronic resource]
260 _bTransplantation proceedings
_cMar 2015
300 _a394-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBK Virus
_xisolation & purification
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xtherapeutic use
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aImmunosuppression Therapy
_xadverse effects
650 0 4 _aKidney
_xvirology
650 0 4 _aKidney Transplantation
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolyomavirus Infections
_xvirology
650 0 4 _aTransplant Recipients
650 0 4 _aTumor Virus Infections
_xdrug therapy
650 0 4 _aViral Load
650 0 4 _aViremia
_xdrug therapy
700 1 _aShah, T
700 1 _aAnsari, J
700 1 _aNaraghi, R
700 1 _aMin, D
773 0 _tTransplantation proceedings
_gvol. 47
_gno. 2
_gp. 394-8
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2015.01.012
_zAvailable from publisher's website
999 _c24706413
_d24706413